Insider Transactions Reported by 6 Insiders of Oncotelic Therapeutics, Inc.

Symbol
OTLC on OTC
Location
Aguora Hills, CA

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Oncotelic Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Vuong Trieu CHAIRMAN AND CEO, Director, 10%+ Owner $7,022,471 22 Jan 2026
Amit B. Shah Chief Financial Officer $9,330 08 Jul 2021
Anthony E. Maida III Chief Clin. Ops. Officer, Director 03 Sep 2021
David Diamond Director 08 Jul 2021
Saran Saund Chief Business Officer 03 Sep 2021
Steven W. King Director 03 Sep 2021

Recent Insider Transactions by Companies or Individuals for Oncotelic Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Vuong Trieu OTLC Series A Convertible Preferred Stock Award 108.9% 4,426 8,491 22 Jan 2026 Direct
Vuong Trieu OTLC Series A Convertible Preferred Stock Award 4,065 4,065 17 Nov 2025 Direct
Vuong Trieu OTLC Common Stock Purchase 0.11% 104,000 93,293,560 10 Jul 2025 Direct
Vuong Trieu OTLC Common Stock Purchase 1 93,293,561 09 Jul 2025 Direct
Vuong Trieu OTLC Common Stock Purchase 0.1% 94,736 93,388,297 08 Jul 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.